Correlation Between Akari Therapeutics and Avenue Therapeutics
Can any of the company-specific risk be diversified away by investing in both Akari Therapeutics and Avenue Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akari Therapeutics and Avenue Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akari Therapeutics PLC and Avenue Therapeutics, you can compare the effects of market volatilities on Akari Therapeutics and Avenue Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akari Therapeutics with a short position of Avenue Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akari Therapeutics and Avenue Therapeutics.
Diversification Opportunities for Akari Therapeutics and Avenue Therapeutics
0.76 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Akari and Avenue is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Akari Therapeutics PLC and Avenue Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avenue Therapeutics and Akari Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akari Therapeutics PLC are associated (or correlated) with Avenue Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avenue Therapeutics has no effect on the direction of Akari Therapeutics i.e., Akari Therapeutics and Avenue Therapeutics go up and down completely randomly.
Pair Corralation between Akari Therapeutics and Avenue Therapeutics
Given the investment horizon of 90 days Akari Therapeutics PLC is expected to generate 0.77 times more return on investment than Avenue Therapeutics. However, Akari Therapeutics PLC is 1.31 times less risky than Avenue Therapeutics. It trades about -0.04 of its potential returns per unit of risk. Avenue Therapeutics is currently generating about -0.07 per unit of risk. If you would invest 1,118 in Akari Therapeutics PLC on August 26, 2024 and sell it today you would lose (988.00) from holding Akari Therapeutics PLC or give up 88.37% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 99.8% |
| Values | Daily Returns |
Akari Therapeutics PLC vs. Avenue Therapeutics
Performance |
| Timeline |
| Akari Therapeutics PLC |
| Avenue Therapeutics |
Akari Therapeutics and Avenue Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Akari Therapeutics and Avenue Therapeutics
The main advantage of trading using opposite Akari Therapeutics and Avenue Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akari Therapeutics position performs unexpectedly, Avenue Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avenue Therapeutics will offset losses from the drop in Avenue Therapeutics' long position.| Akari Therapeutics vs. Capricor Therapeutics | Akari Therapeutics vs. Soleno Therapeutics | Akari Therapeutics vs. Bio Path Holdings | Akari Therapeutics vs. Moleculin Biotech |
| Avenue Therapeutics vs. Capricor Therapeutics | Avenue Therapeutics vs. Akari Therapeutics PLC | Avenue Therapeutics vs. Soleno Therapeutics | Avenue Therapeutics vs. Bio Path Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |